These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26022432)

  • 1. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery.
    Joensuu H; Martin-Broto J; Nishida T; Reichardt P; Schöffski P; Maki RG
    Eur J Cancer; 2015 Aug; 51(12):1611-7. PubMed ID: 26022432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fronts in the adjuvant treatment of GIST.
    Reichardt P; Joensuu H; Blay JY
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients.
    Joensuu H; Reichardt P; Eriksson M; Sundby Hall K; Vehtari A
    Radiology; 2014 Apr; 271(1):96-103. PubMed ID: 24475826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
    Li J; Dang YZ; Gao J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial.
    Majer IM; Gelderblom H; van den Hout WB; Gray E; Verheggen BG
    J Med Econ; 2013 Sep; 16(9):1106-19. PubMed ID: 23808902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
    Centonze D; Pulvirenti E; Pulvirenti D'Urso A; Franco S; Cinardi N; Giannone G
    Tech Coloproctol; 2013 Oct; 17(5):571-4. PubMed ID: 23361497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
    Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
    Tsutsui M; Yoshino S; Sakamoto K; Oka M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2351-3. PubMed ID: 20037419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing GIST in the imatinib era: optimization of adjuvant therapy.
    Trent JC; Subramanian MP
    Expert Rev Anticancer Ther; 2014 Dec; 14(12):1445-59. PubMed ID: 25340579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors.
    Sicklick JK; Lopez NE
    J Gastrointest Surg; 2013 Nov; 17(11):1997-2006. PubMed ID: 23775094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment of GIST: patient selection and treatment strategies.
    Joensuu H
    Nat Rev Clin Oncol; 2012 Apr; 9(6):351-8. PubMed ID: 22525709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
    Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
    J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
    Demetri G; DeMatteo RP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ; Fitzgerald JE; Strauss DC; Hayes AJ; Thomas JM; Messiou C; Fisher C; Benson C; Tekkis PP; Judson I
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
    Lai IR; Hu RH; Chang KJ
    Hepatogastroenterology; 2005; 52(63):826-8. PubMed ID: 15966213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An invasive extragastrointestinal stromal tumor curably resected following imatinib treatment.
    Muto M; Fujiya M; Okada T; Inoue M; Yabuki H; Kohgo Y
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):329-32. PubMed ID: 24078991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors: risk assessment and adjuvant therapy.
    Joensuu H
    Hematol Oncol Clin North Am; 2013 Oct; 27(5):889-904. PubMed ID: 24093166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.